Spinal ependymoma

Reza Yassari MD MS (Dr. Yassari of Albert Einstein College of Medicine has no relevant financial relationships to disclose.)
Jonathan Nakhla MD (Dr. Nakhla of Albert Einstein College of Medicine has no relevant financial relationships to disclose.)
Rafael De la Garza MD (Dr. De la Garza of Albert Einstein College of Medicine has no relevant financial relationships to disclose.)
Rimas V Lukas MD, editor. (Dr. Lukas has received honorariums from AstraZeneca as an advisory board member and AbbVie as a guest speaker.)
Originally released April 7, 1994; last updated October 23, 2017; expires October 23, 2020

Overview

The authors provide an updated summary of spinal ependymomas, highlighting new molecular features of the most common primary intraspinal tumor of adults as well as imaging characteristics. The update includes published epidemiological data, surgical treatment options, comments on the occurrence of these tumors in pregnancy, and updates in the evolving imaging modalities for diagnosis using diffusion tensor imaging.

Historical note and terminology

In 1887, Horsley performed the first reported successful removal of an intradural, extramedullary tumor (Gowers and Horsley 1888). With the help of Sir William Gowers, Horsley removed a "fibromyxoma" overlying the spinal cord at the T4 level. Postoperatively, the patient developed a debilitating pain syndrome but later experienced a full neurologic recovery. In the following 50 years, pioneering neurosurgeons such as Elsberg, Frazier, and Cushing took particular interest in extramedullary tumors, recognizing their frequently benign nature and often dramatic recovery from profound neurologic deficit (Frazier 1918; Elsberg 1925; Cushing and Eisenhardt 1938). In 1911, Elsberg and Beer reported the first successful removal of an intramedullary spinal cord tumor (Elsberg and Beer 1911). Frazier also commented on the potential for the removal of encapsulated intramedullary neoplasms (Frazier 1918). However, early attempts at removal of intrinsic intramedullary spinal cord tumors were associated with serious operative morbidity and mortality, such as complete paralysis.

For the next several decades, there was little impetus to modify the approach of biopsy, dural decompression, and radiation therapy, despite the recognition that after a relatively short remission, serious disability or death ensued. This "traditional" attitude was based on the assumption that it was not feasible to carry out extensive removal of tumors from within the center of the spinal cord without inflicting additional neurologic injury (Coxe 1961; Guidetti et al 1981). In 1954 Greenwood, with the aid of bipolar cautery and loupe magnification, reported 6 patients who underwent complete removal of intramedullary ependymomas (Greenwood 1954). By 1963 Greenwood had treated 9 patients with surgery alone. There was no tumor recurrence in his surviving patients (7) with a mean follow-up of 9 years (Greenwood 1963). With time, it has become clear that the majority of intramedullary spinal ependymomas can be radically excised with an acceptable morbidity and mortality, and a low incidence of recurrence (Guidetti 1967; Mork and Loken 1977; Malis 1978; Stein 1979; Fischer and Mansuy 1980; Guidetti et al 1981; Cooper and Epstein 1985; Cooper 1989; Ahyai et al 1990; McCormick et al 1990; Whitaker et al 1991; Ferrante et al 1992; Clover et al 1993; Epstein et al 1993).

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.